The structures of the title compounds, C9HI4N405 and CgH15N4OsP. H20, have been determined. The nucleoside is monoclinic with a = 10.783 (3), b = 10.206 (3), c = 5.037 (2) A, fl = 94.1 (2) ° , Z = 2, space group P2 r The nucleotide is orthorhombic, space group P212121, with a = 4.777(2), b = 17.259(3), c = 17.077 (3) ,/k, Z = 4. Both structures were solved by direct methods and refined to R = 0.039 and 0.058 for the nucleoside and nucleotide respectively. Ribose puckerings are C(2')-endo,C(3')-exo in the nucleoside and C(2')-exo,C(3')-endo in the nucleotide. The conformation about C(4')-C(5') is gauche-gauche and both molecules exist in the preferred anti form. The nucleotide exists as a zwitterion with N(3) protonated. In both molecules, the 4-carboxamide residue is oriented such that a strong intramolecular hydrogen bond is formed to the amino group at position 5 of the heterocycles. In the crystal structures, all the donor and acceptor groups of the heterocycles are further involved in intermolecular hydrogen bonds.
Introduction 5-Amino-1-fl-D-ribofuranosylimidazole-4-carboxamide 5'-(dihydrogen phosphate) (AICAR-5'-P) plays a role as central intermediate in the biosynthesis of purine nucleotides (Lehninger, 1976; Litchfield & Shaw, 1971 ). Its unique structure shows possibilities of intra-and intermolecular interactions which are important from chemical and biochemical points of view. X-ray analyses of this compound and of the corresponding nucleoside (AICAR) were carried out in order to find a key for suitable chemical substitution to transform this metabolite into an antimetabolite. The atomic nomenclature is depicted in Fig. 1 .
Lorentz and polarization factors but not for absorption. Crystal and intensity-measurement data are given in Table 1 . By the use of Wilson's (1942) method, overall temperature and scale factors were evaluated for both data sets and used to compute normalized structure factors (Karle & Hauptman, 1956) . The structures were solved with MULTAN (Germain, Main & Woolfson, 1970) from all E's > 1.3 for the nucleoside and >1.5 for the nucleotide. In each case, E maps calculated with the most consistent of 64 phase sets revealed the complete structures except the H atoms. Full-matrix least-squares cycles (Busing, Martin & Levy, 1962) were carried out refining non-hydrogen atoms anisotropically. The weighting scheme applied was based on counter statistics with a 2% allowance for machine instability (Stout & Jensen, 1968 Atomic parameters for the nucleoside and nucleotide are listed in Tables 2 and 3 respectively.*
Description of the structures and discussion
The two molecules exist in differently ionized states; the nucleoside is neutral while the nucleotide occurs as a zwitterion with the phosphate group negatively charged and N (3) protonated.
Bond distances and angles are given in Tables 4 and 5, torsion angles in Table 6 . Geometrical data for the imidazole moieties correspond to those described for the neutral and protonated parts in guanine (Voet & Rich, 1970 
THE STRUCTURES OF C9H14N40 5 AND C9HIsN4OaP.H20 elongated N(3)--C(4) and C(4)-C(5) bonds as a result of the amide group substituent. The imidazole rings are planar within +0.01 A, the amide and amino substituents deviating slightly (Table 7) . The latter form a nearly planar six-membered ring, with hydrogen-bond formation between amino group and amide O atom. Partial double-bond character is observed for the unusually short C(4)-C(6) bond (Table 8 ) due to conjugation of the amide group with the imidazole ring.
In the comparable salicylamide acid, C,~-C (1.479 A) is longer than observed here but the C-N and C-O distances are similar (Hsu & Craven, 1974) . Bond lengths and angles in the ribose rings are generally in good agreement with averaged values for the ribose moieties of C(2')-endo and C(3')-endo nucleosides (Saenger & Eckstein, 1970) . Slight deviations may be due to hydrogen-bonding and packing effects. Ribose puckering in the nucleoside is O(l')-C(l') 1.405 (4) O(l')-C(4') 1.453 (5) C(1')-C(2') 1.520 (6) C(l')-N(l) 1.469 (6) C(2')-O(2') 1.421 (5) C(2')-C(3') 1.533 (6) C(3')-O(3') 1.417 (5) C(3')-C(4') 1.516 (6) 1.411 (7) C(4')-C(5') 1.512 (5) 1.509 (8) C(5)-N(5) 1.457 (7) C(5')-O(5') 1.428 ( Nucleoside Nucleotide H atom which, however, could not be located from difference maps.
In the crystal structure of the nucleoside, all potential hydrogen-bond donors and acceptors are involved in hydrogen-bond formation except 0(2') and H(N61) (Figs. 2 and 3 and Table 9 ). In the nucleotide structure, the hydrogen-bonding scheme utilizes all donor and acceptor sites except one donor site at N(6), the scheme being even more complicated due to the presence of a water molecule of hydration. The H atom attached to (Table 10 and Fig. 4) .
A recent systematic study (K/tlmhn, Phrkb, nyi, Schawartz & Simon, 1978) on substituted 5-aminoimidazole-and -1,2,3-triazole-4-carboxamides revealed that in all cases the same intramolecular hydrogen bond is formed between the vicinal 5-arnino and 4-carbox- (A) and angles (o) for possible intermoIecular hydrogen-bonded contacts in the nucleoside THE STRUCTURES OF C9H14N405 AND C9H15N408P.H20 
